泰国柬埔寨边境军事人群疟疾消除策略的整群随机试验研究方案
本研究为在泰国柬埔寨边境军事人员及家属中开展的两臂、整群随机、开放标签试点研究,比较每月疟疾预防(双氢青蒿素-哌喹加每周伯氨喹12周)与聚焦筛查治疗(按柬埔寨国家指南)对疟疾感染风险降低的效果,并评估杀虫剂处理衣物等干预的成本效果。
要点
- 每月疟疾预防方案为双氢青蒿素-哌喹加每周伯氨喹连用12周。
- 主要终点为不同地理营地的疟疾感染风险降低。
- 同时评估诊断方法及G6PD筛查的准确性与成本效果。
核心结论
- 研究旨在比较每月疟疾预防与聚焦筛查治疗两种策略在柬埔寨军事人群中实现疟疾消除的效果。
研究设计与样本
- 两臂、整群随机、开放标签试点研究,在泰国柬埔寨边境军事人员及家属中开展。
- 8个独立军事营地约1000名军事人员及家属随机接受每月疟疾预防或聚焦筛查治疗3个月,另随访3个月。
- 每个治疗集群的军事人员和平民还随机分配接受氯菊酯处理或假(水)处理衣物,采用单盲方式。
关键数值与推荐
- 每月疟疾预防方案:双氢青蒿素-哌喹加每周伯氨喹,持续12周。
- 聚焦筛查治疗遵循当前柬埔寨国家治疗指南。
- 两臂每月通过显微镜、PCR和快速诊断检测进行疟疾筛查,比较检测无症状感染的准确性和成本效果。
- 入组时进行普遍G6PD缺乏症筛查,比较商业快速诊断检测、荧光斑点试验和定量检测的准确性和成本效果。
- 主要终点为基于治疗策略的地理 distinct 军事营地的疟疾感染风险降低。
临床怎么用
- 为边境流动军事人群的疟疾消除策略提供操作要素和成本效果评估。
- 评估杀虫剂处理衣物作为户外叮咬媒介干预的可行性和增量效益。
局限性
- 研究为试点性质,样本量约1000人,可能影响结果的普遍性。
- 开放标签设计可能引入偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Malaria remains a critical public health problem in Southeast Asia despite intensive containment efforts. The continued spread of multi-drug-resistant Plasmodium falciparum has led to calls for malaria elimination on the Thai-Cambodian border. However, the optimal approach to elimination in difficult-to-reach border populations, such as the Military, remains unclear. METHODS/DESIGN: A two-arm, cluster-randomized controlled, open-label pilot study is being conducted in military personnel and their families at focal endemic areas on the Thai-Cambodian border. The primary objective is to compare the effectiveness of monthly malaria prophylaxis (MMP) with dihydroartemisinin-piperaquine and weekly primaquine for 12 weeks compared with focused screening and treating (FSAT) following current Cambodian national treatment guidelines. Eight separate military encampments, making up approximately 1000 military personnel and their families, undergo randomization to the MMP or FSAT intervention for 3 months, with an additional 3 months' follow-up. In addition, each treatment cluster of military personnel and civilians is also randomly assigned to receive either permethrin- or sham (water)-treated clothing in single-blind fashion. The primary endpoint is risk reduction for malaria infection in geographically distinct military encampments based on their treatment strategy. Monthly malaria screening in both arms is done via microscopy, PCR, and rapid diagnostic testing to compare both the accuracy and cost-effectiveness of diagnostic modalities to detect asymptomatic infection. Universal glucose-6-phosphate dehydrogenase (G6PD) deficiency screening is done at entry, comparing the results from a commercially available rapid diagnostic test, the fluorescence spot test, and quantitative testing for accuracy and cost-effectiveness. The comparative safety of the interventions chosen is also being evaluated. DISCUSSION: Despite the apparent urgency, the key operational elements of proposed malaria elimination strategies in Southeast Asian mobile and migrant populations, including the Military, have yet to be rigorously tested in a well-controlled clinical study. Here, we present a protocol for the primary evaluation of two treatment paradigms - monthly malaria prophylaxis and focused screening and treatment - to achieve malaria elimination in a Cambodian military population. We will also assess the feasibility and incremental benefit of outdoor-biting vector intervention - permethrin-treated clothing. In the process, we aim to define the cost-effectiveness of the inputs required for success including a responsive information system, skilled human resource and laboratory infrastructure requirements, and quality management. Despite being a relatively low transmission area, the complexities of multi-drug-resistant malaria and the movement of vulnerable populations require an approach that is not only technically sound, but simple enough to be achievable. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT02653898 . Registered on 13 January 2016.
引用
- Manning J, Lon C, Spring M, et al. Cluster-randomized trial of monthly malaria prophylaxis versus focused screening and treatment: a study protocol to define malaria elimination strategies in Cambodia. Trials. 2018. PMID: 30326952. doi:10.1186/s13063-018-2931-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。